Jefferies raised the firm’s price target on Alphatec (ATEC) to $19 from $16 and keeps a Buy rating on the shares. The firm notes the company pre-announced a strong Q4, driven by both Surgical and EOS, beating consensus by the widest margin this year. It also issued 2025 revenue guide that’s above consensus, and at a level where it can continue to outperform, and expects free cash flow to be positive. Jefferies says that overall, the updates were thesis-confirming, given continued strong volume growth.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATEC: